AlmaCann is a medical cannabis production company that uses data-driven optimising technology and meticulous care to generate the most pharmaceutical-grade cannabis at the lowest cost.
Based in Greece, AlmaCann capitalises on the favourable climate and a highly skilled team to produce the most compliant pharma-grade cannabis in the most cost-efficient way. They achieve this through automation and closely monitoring their entire production process to generate comprehensive data. Their data is fully electronic, tamper-proof, and meets pharmaceutical industry standards. It provides complete traceability and compliance across every step, from seed to packaging. Relying on analytics, sensors and advanced lab equipment, AlmaCann is able to produce cannabis both sustainably and also with great consistency.
AlmaCann is currently in the process of constructing a facility, including a 10,000m² hi-tech greenhouse and ~3,000m² of processing plant building. Combine this with a highly knowledgeable team with big aspirations, AlmaCann is on track to lead and define the future of the cannabis industry across Europe.
Data science for growers
The first automated tech solution for metadata in film
Smart wine investments
First true-to-life physiology platform accessible through the cloud
Unique compostable thermoplastic materials engineered for fashion application
AI for personalised medicine
World's first secure mobile personal health record
Medical production facility
Multidisciplinary building technology and industrial robotics company
Digital queue and visitor flow management system
Modern and powerful B2B laundry and dry cleaning
The World's First and Only Sterile, Disposable, and Feminine Post-Surgical Bra
Mobile accounting app created for SMEs in Africa